About TropIQTropIQ Health Sciences operates a technology platform for the discovery and development of molecules to combat insect-borne infectious diseases. TropIQ combines world-class parasitological and entomological expertise with state of the art drug discovery technologies. Through this combination, TropIQ is uniquely positioned to accelerate the development of novel medicines, vaccines and vector control measures.
- CEO: Koen Dechering
- Affliated department: Medical Microbiology
- Researcher: Robert Sauerwein
- Year of incorporation: 2012